Literature DB >> 6782229

Blood level and brain distribution of thyrotropin-releasing hormone (TRH) determined by radioimmunoassay after intravenous administration in rats.

Y Nagai, S Yokohama, Y Nagawa, Y Hirooka, N Nihei.   

Abstract

The blood level and brain distribution of immunoreactive TRH after intravenous administration of TRH tartrate monohydrate (TRH-T) were investigated by radioimmunoassay in rats. Optimal condition for complete inactivation of TRH-degradative enzymes in brain by a microwave irradiation was found to be a 5kW power for 1.5 seconds. The endogenous TRH was present at the highest concentration in the hypothalamus, followed by the brain stem and thalamus, and was the lowest in the cerebral cortex including hippocampus and cerebellum. The time-course of TRH blood levels following administration of TRH-T at 0.5, 5 and 25 mg/kg fitted to a two compartment open model, and the half-lives in beta-phase increased dose-dependently. The administered TRH was incorporated rapidly from blood into whole brain, and the peak brain level corresponding to 0.108--0.166% of the total dose administered was attained 1 min after the administration. The brain TRH was eliminated with a half-life of about 3 min. The administered TRH was distributed throughout the brain, at the highest concentration in the hypothalamus, followed by the brain stem, cerebellum, thalamus and cerebral cortex. TRH tended to be eliminated most rapidly from the cerebellum.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6782229     DOI: 10.1248/bpb1978.3.500

Source DB:  PubMed          Journal:  J Pharmacobiodyn        ISSN: 0386-846X


  3 in total

1.  Acute effects of high-dose thyrotropin releasing hormone infusions in Alzheimer's disease.

Authors:  A M Mellow; T Sunderland; R M Cohen; B A Lawlor; J L Hill; P A Newhouse; M R Cohen; D L Murphy
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Prodrugs of peptides. 6. Bioreversible derivatives of thyrotropin-releasing hormone (TRH) with increased lipophilicity and resistance to cleavage by the TRH-specific serum enzyme.

Authors:  H Bundgaard; J Møss
Journal:  Pharm Res       Date:  1990-09       Impact factor: 4.200

3.  Effects of thyrotropin releasing hormone on human sudomotor and cutaneous vasomotor activities.

Authors:  J Sugenoya; M Kihara; T Ogawa; A Takahashi; T Mitsuma; Y Yamashita
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1988
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.